ProGyno
Probiotic for Women’s Health
WHAT IT IS:
- An oral probiotic pairing Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14® – the two most extensively researched strains for restoring and maintaining healthy female urogenital flora
WHY YOU NEED IT:
- Important for women with vaginal Candida, bacterial vaginosis, recurrent UTIs, and imbalances due to the use of antibiotics and other conditions.
- ProGyno contains 2 billion CFU of a proprietary blend of two clinically documented strains
- GR-1® and RC-14® have been studied together for more than two decades, with published work spanning bacterial vaginosis, yeast overgrowth and recurrent urinary tract infection
- Can be taken by mouth – or vaginally
- In a controlled trial of 64 women with bacterial vaginosis, adding these strains to standard treatment produced markedly higher resolution rates than treatment alone
- A randomized study of 55 women found significantly less Candida presence in the probiotic group compared with placebo
- Valuable support after a course of antibiotics, which disrupt protective flora along with the targeted organism
- Convenient once-daily capsule
HOW IT HELPS:
A healthy vaginal environment is dominated by the healthy bacteria, lactobacilli. These organisms produce lactic acid that keeps the local pH low, generate hydrogen peroxide and antimicrobial compounds, and physically occupy the surface sites that unwanted bacteria and yeast would otherwise colonize. When that protective population thins – after antibiotics, with hormonal shifts, with stress, or after illness – the vaginal landscape can change unfavorably, and less desirable organisms take advantage.
GR-1 and RC-14 were selected from extensive screening of urogenital isolates for exactly these properties: blocking the growth of both bacterial and fungal pathogens, reducing pathogen adhesion to the cells lining the urinary tract, and making it harder for problem organisms to establish a foothold in the urogenital region.
The oral route works because these particular strains survive digestion, transit the intestine, and reach the urogenital tract by natural migration. Molecular fingerprinting studies confirmed their presence in the vaginal tract well after dosing.
The record of meaningful clinical research is strong. In a randomized trial of women with bacterial vaginosis, participants receiving GR-1 and RC-14 alongside standard antimicrobial treatment had a resolution rate of approximately 75 percent, compared with roughly a third in the placebo group, and a substantially lower prevalence of bacterial vaginosis at study endpoint. Investigators concluded these strains have real potential to restore normal urogenital microbiota and thereby reduce risk of urinary tract infection, bacterial vaginosis and yeast vaginitis.
Dosage:
Take one capsule daily, with or without food. For additional and direct support, insert one capsule vaginally at bedtime. If you are taking an antibiotic, separate the two by at least two hours. A typical restorative course runs four to twelve weeks; longer maintenance use is appropriate for some patients.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The Center for Integrative Medicine • Michael Hirt, M.D. • 5620 Wilbur Avenue, Suite 220, Tarzana, CA 91356 • 818.345.2828